BridgeMD
New treatment option for Essential Hypertension
Official title Effects of Remote Ischemic Conditioning on Blood Pressure in Older Patients With Hypertension
ClinicalTrials.gov ID: NCT05845905
What this study is testing
- What it's testing
- The purpose of this study is to learn about effects of remote ischemic conditioning on blood pressure in older patients with essential hypertension.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 65 to 85
You may be able to join if
- 1) Age ≥65 years and ≤85 years, regardless of gender;
- 2) History of essential hypertension and clinical systolic blood pressure ≥ 140 mmHg, regardless of whether they are receiving antihypertensive...
- 3) Willing to participate and sign the informed consent.
You likely can't join if
- 1) Secondary hypertension;
- 2) Clinical blood pressure ≥ 180/110 mmHg or 24-hour mean arterial pressure ≥ 170/100 mmHg;
- 3) Severe organ dysfunction or failure;
- 4) Severe hematologic disorders or significant coagulation abnormalities;
- 5) History of atrial fibrillation or myocardial infarction within 6 months;
- 6) Individuals who had contraindication of remote ischemic conditioning, such as severe soft tissue injury, fracture or vascular injury in the upper...
See the full eligibility criteria
- 1) Age ≥65 years and ≤85 years, regardless of gender;
- 2) History of essential hypertension and clinical systolic blood pressure ≥ 140 mmHg, regardless of whether they are receiving antihypertensive medication;
- 3) Willing to participate and sign the informed consent.
- 1) Secondary hypertension;
- 2) Clinical blood pressure ≥ 180/110 mmHg or 24-hour mean arterial pressure ≥ 170/100 mmHg;
- 3) Severe organ dysfunction or failure;
- 4) Severe hematologic disorders or significant coagulation abnormalities;
- 5) History of atrial fibrillation or myocardial infarction within 6 months;
- 6) Individuals who had contraindication of remote ischemic conditioning, such as severe soft tissue injury, fracture or vascular injury in the upper limb, acute or subacute venous thrombosis, arterial occlusive disease...
- 7) Individuals who will or have received anticoagulant therapy with drugs such as dabigatran, rivaroxaban, warfarin, etc;
- 8) Those who are participating in other clinical research or has participated in other clinical research or has participated in this study within 3 months prior to enrollment;
- 9) Other conditions that the researchers think are not suitable for the project.
The study team makes the final eligibility decision.
Where it's taking place
- Changchun, Jilin, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 65 years to 85 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Changchun, Jilin, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.